Inhibitory Effect of a Somatostatin Analogue (SMS 201–995) on the Growth of Androgen‐dependent Mouse Mammary Tumor (Shionogi Carcinoma 115)

Japanese Journal of Cancer Research

Volumn 84, Issue 6, 1993, Pages 656-663

  Noguchi, Shinzaburo ^a   Nishizawa, Yasuko ^a   Motomura, Kazuyoshi ^a   Inaji, Hideo ^a   Imaoka, Shingi ^a   Koyama, Hiroki ^a   Matsumoto, Keishi ^b  

^a CENTER FOR ADULT DISEASES   (Japan)

^b RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

Author keywords

Androgen; Growth hormone; Mammary tumor; Somatostatin

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; GROWTH HORMONE; OCTREOTIDE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; GROWTH HORMONE RELEASE; HORMONE DEPENDENCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SUBCUTANEOUS DRUG ADMINISTRATION; TESTOSTERONE BLOOD LEVEL; TUMOR CELL; TUMOR GROWTH;

ANIMAL; CELL DIVISION; GROWTH HORMONE; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED STRAINS; NEOPLASM TRANSPLANTATION; NEOPLASMS, HORMONE-DEPENDENT; OCTREOTIDE; RECEPTORS, ANDROGEN; RECEPTORS, SOMATOSTATIN; TESTOSTERONE; TUMOR CELLS, CULTURED;

EID: 0027249713     PISSN: 09105050     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1993.tb02026.x     Document Type: Article

References (36)

1. Hypothalamic polypeptides that inhibit the secretion of immunoreactive pituitary growth hormone
2. 17β‐Estradiol induces somatostatin (SRIF) inhibition of prolactin release and regulates SRIF receptors in rat anterior pituitary cells
3. Somatostatin
4. Oncological application of somatostatin analogues
5. Somatostatin and analogues in the treatment of cancer
6. Somatostatin and octreotide: literature review and description of therapeutic activity in pancreatic neoplasia
7. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells
8. Inhibition of growth of human breast carcinomas in vivo by somatostatin analog SMS 201–995: treatment of nude mouse xenografts
9. Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatin
10. Treatment of R‐3327 prostate tumors with a somatostatin analogue (Somatuline) as adjuvant therapy following surgical castration
11. Histologic changes in the rat prostate cancer model after treatment with somtatostain analogs and D‐Trp‐6‐LH‐RH
12. An androgen‐dependent tumor derived from a hormone‐independent spontaneous tumor of female mouse
13. An androgen‐dependent mouse mammary tumor
14. Role of androgen and its receptors in mouse mammary tumor
15. The metabolism and binding of testosterone in androgen‐dependent and autonomous transplantable mouse mammary tumors
16. Cloned mouse mammary cell lines requiring androgens for growth in culture
17. The role of receptors in the steroidal regulation of tumor cell proliferation
18. Two sex steroid receptors in SC–115 mammary tumor cells
19. Proliferation of Shionogi carcinoma cells caused by androgen‐induced fibroblast growth factor (FGF)‐like peptide in an autocrine mechanism
20. Growth hormone enhances hepatic epidermal growth factor receptor concentration in mice
21. Growth‐stimulating effect of pharmacological doses of estrogen on androgen‐dependent Shionogi Carcinoma 115 in vivo but not in cell culture
22. Growth‐stimulative effect of estrogen on androgen‐dependent Shionogi Carcinoma 115
23. The attractions of proteins from small molecules and ions
24. Evaluation of receptors for somatostatin in various tumors using different analogs
25. Effect of serial passage in female nude athymic mice on androgen dependency of Shionogi Carcinoma 115
26. Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa‐2 cell line
27. Age and sex related differences in episodic growth hormone secretion in the rat
28. Physiological secretion of growth hormone and prolactin in male and female rats
29. Regulation of sexually dimorphic hepatic steroid metabolism by the somatostatin‐growth hormone axis
30. Sites of action of testosterone and estradiol on longitudinal bone growth
31. Insulin‐like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations
32. Secretory patterns of growth hormone and insulin‐like growth factor I during peripubertal period in intact and castrate male cattle
33. Hormonal regulation of the peripubertal surge of insulin‐like growth factor‐I in the rats
34. Role of testosterone in regulating the growth of mice from lines for low v.s. high plasma insulin‐like growth factor‐I concentrations
35. Effects of androgen, fibroblast growth factors or other various growth factors on growth of Shionogi carcinoma cells in a protein‐free medium
36. Three cell lines showing androgendependent, ‐independent, and ‐suppressed phenotypes, established from a single tumor of androgen‐dependent Shionogi carcinoma 115